A citation-based method for searching scientific literature

Payal D Shah, Katherine L Nathanson. Annu Rev Genomics Hum Genet 2017
Times Cited: 21







List of co-cited articles
75 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
47

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
33

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
269
28

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
197
28

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.
Stephen E Lincoln, Yuya Kobayashi, Michael J Anderson, Shan Yang, Andrea J Desmond, Meredith A Mills, Geoffrey B Nilsen, Kevin B Jacobs, Federico A Monzon, Allison W Kurian,[...]. J Mol Diagn 2015
110
19

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
Lisa R Susswein, Megan L Marshall, Rachel Nusbaum, Kristen J Vogel Postula, Scott M Weissman, Lauren Yackowski, Erica M Vaccari, Jeffrey Bissonnette, Jessica K Booker, M Laura Cremona,[...]. Genet Med 2016
152
19

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
799
14

Gene panel testing for inherited cancer risk.
Michael J Hall, Andrea D Forman, Robert Pilarski, Georgia Wiesner, Veda N Giri. J Natl Compr Canc Netw 2014
78
14

The current state of clinical interpretation of sequence variants.
Derick C Hoskinson, Adrian M Dubuc, Heather Mason-Suares. Curr Opin Genet Dev 2017
47
14

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
156
14

Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
Laura M Amendola, Michael O Dorschner, Peggy D Robertson, Joseph S Salama, Ragan Hart, Brian H Shirts, Mitzi L Murray, Mari J Tokita, Carlos J Gallego, Daniel Seung Kim,[...]. Genome Res 2015
215
14


ClinVar: public archive of interpretations of clinically relevant variants.
Melissa J Landrum, Jennifer M Lee, Mark Benson, Garth Brown, Chen Chao, Shanmuga Chitipiralla, Baoshan Gu, Jennifer Hart, Douglas Hoffman, Jeffrey Hoover,[...]. Nucleic Acids Res 2016
14

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
296
14

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.
Hermela Shimelis, Holly LaDuca, Chunling Hu, Steven N Hart, Jie Na, Abigail Thomas, Margaret Akinhanmi, Raymond M Moore, Hiltrud Brauch, Angela Cox,[...]. J Natl Cancer Inst 2018
110
14

Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Jordan Lerner-Ellis, Sam Khalouei, Victoria Sopik, Steven A Narod. Expert Rev Anticancer Ther 2015
31
14

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bartłomiej Masojć, Tadeusz Deebniak, Bohdan Górski, Paweł Blecharz,[...]. J Clin Oncol 2011
125
14

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.
Allison W Kurian, Kevin C Ward, Nadia Howlader, Dennis Deapen, Ann S Hamilton, Angela Mariotto, Daniel Miller, Lynne S Penberthy, Steven J Katz. J Clin Oncol 2019
90
14

An integrated map of genetic variation from 1,092 human genomes.
Goncalo R Abecasis, Adam Auton, Lisa D Brooks, Mark A DePristo, Richard M Durbin, Robert E Handsaker, Hyun Min Kang, Gabor T Marth, Gil A McVean. Nature 2012
9

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.
Kai Wang, Mingyao Li, Hakon Hakonarson. Nucleic Acids Res 2010
9


Coming of age: ten years of next-generation sequencing technologies.
Sara Goodwin, John D McPherson, W Richard McCombie. Nat Rev Genet 2016
9

PALB2/FANCN: recombining cancer and Fanconi anemia.
Marc Tischkowitz, Bing Xia. Cancer Res 2010
122
9

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
472
9

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
482
9

MutationTaster evaluates disease-causing potential of sequence alterations.
Jana Marie Schwarz, Christian Rödelsperger, Markus Schuelke, Dominik Seelow. Nat Methods 2010
9

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
Mario Capasso, Marcella Devoto, Cuiping Hou, Shahab Asgharzadeh, Joseph T Glessner, Edward F Attiyeh, Yael P Mosse, Cecilia Kim, Sharon J Diskin, Kristina A Cole,[...]. Nat Genet 2009
214
9


The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.
Marketa Janatova, Zdenek Kleibl, Jana Stribrna, Ales Panczak, Kamila Vesela, Martina Zimovjanova, Petra Kleiblova, Pavel Dundr, Jana Soukupova, Petr Pohlreich. Cancer Epidemiol Biomarkers Prev 2013
32
9

The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
Thales C Nepomuceno, Giuliana De Gregoriis, Francisco M Bastos de Oliveira, Guilherme Suarez-Kurtz, Alvaro N Monteiro, Marcelo A Carvalho. Int J Mol Sci 2017
44
9

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
9

Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients.
F Lhota, P Zemankova, P Kleiblova, J Soukupova, M Vocka, V Stranecky, M Janatova, H Hartmannova, K Hodanova, S Kmoch,[...]. Clin Genet 2016
26
9

Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma.
Ondrej Havranek, Petra Kleiblova, Jan Hojny, Filip Lhota, Pavel Soucek, Marek Trneny, Zdenek Kleibl. PLoS One 2015
18
11



The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.
Zdenek Kleibl, Ondrej Havranek, Ivona Hlavata, Jan Novotny, Jan Sevcik, Petr Pohlreich, Pavel Soucek. Eur J Cancer 2009
33
9

Guidelines for diagnostic next-generation sequencing.
Gert Matthijs, Erika Souche, Mariëlle Alders, Anniek Corveleyn, Sebastian Eck, Ilse Feenstra, Valérie Race, Erik Sistermans, Marc Sturm, Marjan Weiss,[...]. Eur J Hum Genet 2016
226
9

What can exome sequencing do for you?
Jacek Majewski, Jeremy Schwartzentruber, Emilie Lalonde, Alexandre Montpetit, Nada Jabado. J Med Genet 2011
209
9

Inherited susceptibility to common cancers.
William D Foulkes. N Engl J Med 2008
311
9

ClinVar: public archive of relationships among sequence variation and human phenotype.
Melissa J Landrum, Jennifer M Lee, George R Riley, Wonhee Jang, Wendy S Rubinstein, Deanna M Church, Donna R Maglott. Nucleic Acids Res 2014
9

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
Rachel Pearlman, Wendy L Frankel, Benjamin Swanson, Weiqiang Zhao, Ahmet Yilmaz, Kristin Miller, Jason Bacher, Christopher Bigley, Lori Nelsen, Paul J Goodfellow,[...]. JAMA Oncol 2017
247
9

Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
Carin R Espenschied, Holly LaDuca, Shuwei Li, Rachel McFarland, Chia-Ling Gau, Heather Hampel. J Clin Oncol 2017
73
9

Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Nimmi S Kapoor, Lisa D Curcio, Carlee A Blakemore, Amy K Bremner, Rachel E McFarland, John G West, Kimberly C Banks. Ann Surg Oncol 2015
66
9

Routine use of gene panel testing in hereditary breast cancer should be performed with caution.
Cedric van Marcke, Anne De Leener, Martine Berlière, Miikka Vikkula, Francois P Duhoux. Crit Rev Oncol Hematol 2016
14
14

Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice.
Christina G Selkirk, Kristen J Vogel, Anna C Newlin, Scott M Weissman, Shelly M Weiss, Chi-Hsiung Wang, Peter J Hulick. Fam Cancer 2014
26
9

Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Thaddeus Judkins, Benoît Leclair, Karla Bowles, Natalia Gutin, Jeff Trost, James McCulloch, Satish Bhatnagar, Adam Murray, Jonathan Craft, Bryan Wardell,[...]. BMC Cancer 2015
71
9

Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk.
Erin O'Leary, Daniela Iacoboni, Jennifer Holle, Scott T Michalski, Edward D Esplin, Shan Yang, Karen Ouyang. Ann Surg Oncol 2017
27
9

Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer.
J Brian Szender, Jasmine Kaur, Katherine Clayback, Mollie L Hutton, June Mikkelson, Kunle Odunsi, Cara Dresbold. Int J Gynecol Cancer 2018
5
40

Organizing knowledge to enable personalization of medicine in cancer.
Benjamin M Good, Benjamin J Ainscough, Josh F McMichael, Andrew I Su, Obi L Griffith. Genome Biol 2014
36
9

The Sequence Ontology: a tool for the unification of genome annotations.
Karen Eilbeck, Suzanna E Lewis, Christopher J Mungall, Mark Yandell, Lincoln Stein, Richard Durbin, Michael Ashburner. Genome Biol 2005
408
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.